Search

Search Constraints

You searched for: Author/Creator Henn, Matt

Search Results

8. LB15. SER-109, an Investigational Microbiome Therapeutic, Reduces Abundance of Antimicrobial Resistance Genes in Patients with Recurrent Clostridioides difficile Infection (rCDI) after Standard-of-Care Antibiotics. (4th December 2021)